Clinical Trial Update: Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial [Phase 2]

View source ↗

Summary

This is a Phase II, single-arm clinical trial evaluating ivonescimab in combination with chemotherapy as first-line treatment for relapsed or metastatic thymic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Cancer

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Relapsed or Metastatic Thymic Cancer, First-line Treatment | Phase 2 | Status: NOT_YET_RECRUITING